Wall Street Close: Stocks ended mixed after vaccine roll-out
- The Dow Jones Industrial Average fell 0.62% to end at 29,859.97 points.
- The S&P 500 SPX lost 0.44% to 3,647.33.
- The Nasdaq Composite climbed 0.5% to 12,440.04.
Despite the roll-out of the COVID-19 vaccine campaign in the United States, US stocks were mixed by the close.
The Dow Jones Industrial Average touched a record high before ending lower,
A Pfizer PFE and its German partner BioNTechBNTX began on Monday to administer the vaccine following emergency-use approval from federal regulators last week.
The S&P 500 gave up earlier gains of almost 1%. Unofficially, the Dow Jones Industrial Average lost 0.62% to end at 29,859.97 points, while the S&P 500 SPX fell 0.44% to 3,647.33. The Nasdaq Composite added 0.5% to 12,440.04.
Meanwhile, additional coronavirus relief remains elusive after the Senate last week approved a one-week extension of federal funding to avoid a government shutdown.
Investors were also focused on early voting in a pair of US Senate races in Georgia that will determine control of the chamber and heavily influence lawmaking. The latter will help determine the future path of Biden’s fiscal policy.
Author
Ross J Burland
FXStreet
Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.
